⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
SPRY News
ARS Pharmaceuticals, Inc. Common Stock
Securities Class Action Lawsuit Filed Against ARS Pharmaceuticals, Inc. (SPRY) - Levi & Korsinsky Represents Shareholders
accessnewswire.com
SPRY
SPRY INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that ARS Pharmaceuticals Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit!
accessnewswire.com
SPRY
Lost Money on ARS Pharmaceuticals, Inc. (SPRY)? Urged to Join Class Action Before October 5, 2026 - Contact Levi & Korsinsky
accessnewswire.com
SPRY
SPRY Investors Have Opportunity to Lead ARS Pharmaceuticals, Inc. Securities Fraud Lawsuit with SBS Law
globenewswire.com
SPRY
SPRY Shareholder Alert: Investors With Losses May Seek to Lead the Class Action in ARS Pharmaceuticals Securities Lawsuit - Contact SueWallSt
globenewswire.com
SPRY
Important Notice to Long-Term Shareholders of ARS Pharmaceuticals, Inc. (NASDAQ: SPRY); Hub Group, Inc. (NASDAQ: HUBG); Insulet Corporation (NASDAQ: PODD); and Roblox Corporation (NYSE: RBLX): Grabar Law Office is Investigating Claims on Your Behalf
globenewswire.com
SPRY
HUBG
PODD
RBLX
SPRY EQUITY ACTION REMINDER: Faruqi & Faruqi, LLP Reminds ARS Pharmaceuticals Investors of Securities Class Action Lawsuit Deadline on October 5, 2026 Ready to Announce with Confidence?
newsfilecorp.com
SPRY
Levi & Korsinsky Notifies ARS Pharmaceuticals, Inc. (SPRY) Shareholders of Class Action Lawsuit and October 5, 2026 Deadline
accessnewswire.com
SPRY
ARS Pharmaceuticals, Inc. (SPRY) Lawsuit - Investors Urged to Contact Levi & Korsinsky Before October 5, 2026
accessnewswire.com
SPRY
SPRY Investors Have Opportunity to Lead ARS Pharmaceuticals, Inc. Securities Fraud Lawsuit
prnewswire.com
SPRY